These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6516411)

  • 1. [Recent clinical knowledge of cytoplasmic substances in myogenic and neuromuscular diseases, especially in muscular dystrophy, Duchenne type].
    Beckmann R
    Wien Klin Wochenschr; 1984 Aug; 96(16):599-611. PubMed ID: 6516411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy.
    D'Amore PA; Brown RH; Ku PT; Hoffman EP; Watanabe H; Arahata K; Ishihara T; Folkman J
    Ann Neurol; 1994 Mar; 35(3):362-5. PubMed ID: 8122890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum myosin light chain 3 level in neuromuscular diseases.
    Konagaya M; Konagaya Y; Horikawa H; Takayanagi T
    Muscle Nerve; 1987 Jun; 10(5):415-21. PubMed ID: 3112571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic studies in patients and relatives with hereditary neuromuscular diseases].
    Moser H
    Ther Umsch; 1995 Dec; 52(12):810-3. PubMed ID: 8539652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of neuromuscular diseases.
    Chance PF; Ashizawa T; Hoffman EP; Crawford TO
    Phys Med Rehabil Clin N Am; 1998 Feb; 9(1):49-81, vi. PubMed ID: 9894134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle MRI in inherited neuromuscular disorders: past, present, and future.
    Mercuri E; Pichiecchio A; Allsop J; Messina S; Pane M; Muntoni F
    J Magn Reson Imaging; 2007 Feb; 25(2):433-40. PubMed ID: 17260395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular diseases in children.
    Roper HP
    Br J Hosp Med; 1993 Apr 21-May 4; 49(8):537, 540-5. PubMed ID: 8508238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte alkaline phosphatase in patients with myotonic muscle disorders.
    Goldemberg AL; Madrid EA; García AM; Roubicek M; Esteban Trucco R
    Invest Clin; 1996 Dec; 37(4):247-53. PubMed ID: 8968130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis between Duchenne and Becker types muscular dystrophy.
    Ishpekova B; Milanov I; Christova LG; Alexandrov AS
    Electromyogr Clin Neurophysiol; 1999; 39(5):315-8. PubMed ID: 10422002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
    Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
    Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in neuromuscular disorders.
    D'Angelo MG; Bresolin N
    Muscle Nerve; 2006 Jul; 34(1):16-33. PubMed ID: 16544320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical models of rehabilitation in neuromuscular disease.
    Vignos PJ
    Muscle Nerve; 1983 Jun; 6(5):323-38. PubMed ID: 6888414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Muscular hypertrophy in clinical neurology (author's transl)].
    Verret JM; Lapresle J
    Acta Neurol Belg; 1981; 81(1):33-51. PubMed ID: 7223356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The genetic basis of muscle disease].
    Bindoff L; Gilhus NE
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2588-92. PubMed ID: 14714051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various features of muscle tissue metabolism in various muscular and neuromuscular diseases of a hereditary nature (clinico-histochemical study)].
    Anosov NN; Saĭkova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):22-5. PubMed ID: 6952668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience].
    Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM
    J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of cytoplasmic body in neuromuscular diseases].
    Akiyama C; Sakuta R; Matsuoka T; Nonaka I
    Rinsho Shinkeigaku; 1993 Mar; 33(3):278-81. PubMed ID: 8392918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of histopathological pattern of neuromuscular disorders with clinico-pathologic correlation.
    Karim MS; Kamal M; Rahman AJ
    Bangladesh Med Res Counc Bull; 2003 Apr; 29(1):11-22. PubMed ID: 14674616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of vascular endothelial growth factor elevated in patients with muscular dystrophy.
    Saito T; Yamamoto Y; Matsumura T; Fujimura H; Shinno S
    Brain Dev; 2009 Sep; 31(8):612-7. PubMed ID: 18980821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early clinical and histopathological manifestations in 14 boys showing elevated serum creatine-phosphokinase levels in their first year].
    Guibaud P; Carrier HN; Plauchu H; Lauras B; Jolivet MJ; Robert JM
    J Genet Hum; 1981 Mar; 29(1):71-84. PubMed ID: 7334343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.